SCHEMBL17037097

SCHEMBL17037097

N#Cc1ccc2c(c1)sc1c3ccc(-c4ccccc4)cc3sc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LIMK1 P53667 3/20 0.51
▸ G6PD P11413 2/20 0.43
▸ GABRA1 P14867 2/20 0.43
▸ GABRG2 P18507 2/20 0.43
▸ GABRB3 P28472 2/20 0.43
▸ GABRA5 P31644 2/20 0.43
▸ GABRA3 P34903 2/20 0.43
▸ ACLY P53396 1/20 0.39
▸ MYC P01106 1/20 0.38
▸ CYP19A1 P11511 1/20 0.38
▸ APP P05067 1/20 0.38
▸ CSNK1A1 P48729 1/20 0.37
▸ CSNK1D P48730 1/20 0.37
▸ GSK3B P49841 1/20 0.37
▸ CSNK1G2 P78368 1/20 0.37
▸ CYP17A1 P05093 1/20 0.37
▸ CYP11B1 P15538 1/20 0.37
▸ CYP11B2 P19099 1/20 0.37
▸ PTPN5 P54829 1/20 0.37
▸ PRSS12 P56730 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17037110 0.93 LIMK1 (0.48) LIMK1G6PDGABRA1GABRG2GABRB3
SCHEMBL26525944 0.85 LIMK1 (0.57) LIMK1PIK3CAPI4KAPI4KB
SCHEMBL18470271 0.85 LIMK1 (0.57) LIMK1PIK3CAPI4KAPI4KB
SCHEMBL1230128 0.85 LIMK1 (0.57) LIMK1PIK3CAPI4KAPI4KB
SCHEMBL23555984 0.85 LIMK1 (0.57) LIMK1PIK3CAPI4KAPI4KB
SCHEMBL23555670 0.85 LIMK1 (0.57) LIMK1PIK3CAPI4KAPI4KB
SCHEMBL18429798 0.85 LIMK1 (0.57) LIMK1PIK3CAPI4KAPI4KB
SCHEMBL18470285 0.85 LIMK1 (0.57) LIMK1PIK3CAPI4KAPI4KB
SCHEMBL10300258 0.84 ASIC3 (0.50) LIMK1APPPIK3CAPI4KAPI4KB
SCHEMBL17037096 0.83 G6PD (0.44) LIMK1G6PDAPPPRSS12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9260451-B2 Method for producing aromatic compound NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2016-02-16 — — US disclosed
US-9260451-B2 Method for producing aromatic compound NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2016-02-16 — — US disclosed
US-20150239901-A1 Method For Producing Aromatic Compound NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2015-08-27 — — US disclosed
US-20150239901-A1 Method For Producing Aromatic Compound NIPPON KAYAKU KABUSHIKI KAISHA (JP) 2015-08-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150239901-A1 Method For Producing Aromatic Compound TYR, XDH, CYP1A1 LIMK1 3787/4885G6PD 1874/4885GABRA1 3269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback